Sickle cell disease in India: Not just a mild condition

被引：0
|
作者：
Kochhar, Manpreet [1 ,2 ]
McGann, Patrick T. [1 ,2 ]
机构：
[1] Brown Univ, Dept Pediat, Div Pediat Hematol Oncol, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Hlth Sickle Cell Ctr, Providence, RI USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 01期
关键词：
sickle cell; sickle cell disease; vaso-occlusive; LOW-DOSE HYDROXYUREA; FETAL-HEMOGLOBIN; ANEMIA;
D O I：
10.1111/bjh.19877
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sickle cell disease (SCD) is a common and life-threatening global health problem, with more than 500 000 affected infants born annually. The burden of SCD in sub-Saharan Africa is well established, but the comparably high prevalence in India is not well recognized and many consider SCD in India to be less severe. In their paper, a national study in India demonstrated the significant impact of SCD for patients, families and the healthcare system, supporting a call to action to recognize and address SCD as a serious and common health condition in India. Commentary on: Seth et al. Burden of vaso-occlusive crisis, its management, and impact on quality of life of Indian sickle cell disease patients. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19829.
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [21] Sickle cell disease treatment and management in India: a systematic review of interventional studies
    Sridevi, Parikipandla
    Sharma, Yogita
    Balakrishna, Sunnam L.
    Babu, Bontha, V
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (12) : 1101 - 1111
  • [22] Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype
    Italia, Khushnooma
    Kangne, Harshada
    Shanmukaiah, Chandrakala
    Nadkarni, Anita H.
    Ghosh, Kanjaksha
    Colah, Roshan B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 156 - 159
  • [23] Sickle Cell Disease
    Pohl, Elizabeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (05) : 605 - 607
  • [24] Cerebral hemodynamics in children with sickle cell disease in India: An observational cohort study
    Gajjar, Bhakti
    Sharma, Sanjay
    Khan, Erum
    Sharma, Pranita
    Jain, Pawan
    Goel, Vikas
    Neral, Arvind
    Patel, Jyotish
    Parmar, Mamta
    Sharma, Kanika
    Sharma, Vijay K.
    Sharma, Arvind K.
    MEDICINE, 2022, 101 (27) : E29882
  • [25] Current status of sickle cell disease in India: how can you attenuate?
    Dipika Mohanty
    Molecular Cytogenetics, 7 (Suppl 1)
  • [26] Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India
    Upadhye, Dipti S.
    Jain, Dipty L.
    Trivedi, Yogesh L.
    Nadkarni, Anita H.
    Ghosh, Kanjaksha
    Colah, Roshan B.
    PLOS ONE, 2016, 11 (01):
  • [27] Homozygous sickle cell disease in Central India & Jamaica: A comparison of newborn cohorts
    Jain, Dipty
    Tokalwar, Rajini
    Upadhye, Dipti
    Colah, Roshan
    Serjeant, Graham Roger
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (04) : 326 - 332
  • [28] Pathophysiology of sickle cell disease and therapeutic perspectives
    Allali, Slimane
    Pinhas, Yael
    Maciel, Thiago Trovati
    Hermine, Olivier
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (05): : 648 - 659
  • [29] Therapeutics for sickle cell disease intravascular hemolysis
    Xue, Jianyao
    Li, Xiang-An
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [30] Biomarker signatures of sickle cell disease severity
    Du, Mengtian
    Van Ness, Sarah
    Gordeuk, Victor
    Nouraie, Sayed M.
    Nekhai, Sergei
    Gladwin, Mark
    Steinberg, Martin H.
    Sebastiani, Paola
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 72 : 1 - 9
12345